New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age.

Autor: Kinter LB; Safety Assessment U.S., Development, AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437, USA. lewis.kinter@astrazeneca.com, Siegl PK, Bass AS
Jazyk: angličtina
Zdroj: Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2004 May-Jun; Vol. 49 (3), pp. 153-8.
DOI: 10.1016/j.vascn.2004.03.007
Databáze: MEDLINE